This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Csl Behring Gmbh. Active years: 2017-2019.
Company Filing History:
Years Active: 2017-2019
Title: Wilfried Wormsbaecher: Innovator in Hemophilia Treatment
Introduction
Wilfried Wormsbaecher is a notable inventor based in Kirchhain, Germany. He has made significant contributions to the field of medical treatments, particularly in the area of hemophilia. With a total of 2 patents to his name, Wormsbaecher's work focuses on innovative sugar compositions that aim to improve the lives of individuals suffering from blood disorders.
Latest Patents
Wormsbaecher's latest patents include groundbreaking inventions related to sugar compositions for treating hemophilia A and Von Willebrand disease. The first patent describes compositions comprising an isolated sugar for use in the treatment of these conditions, specifically utilizing an accessible sugar residue derived from ABO(H) blood group antigen. This innovative approach has the potential to enhance treatment efficacy for patients affected by these disorders.
Career Highlights
Throughout his career, Wormsbaecher has been associated with Csl Behring GmbH, a company known for its commitment to developing therapies for rare and serious diseases. His work has not only contributed to the advancement of medical science but has also positioned him as a key figure in the field of hemophilia research.
Collaborations
Wormsbaecher has collaborated with esteemed colleagues such as Stefan Schulte and Rolf Spirig. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately benefiting the research community and patients alike.
Conclusion
Wilfried Wormsbaecher's contributions to the treatment of hemophilia through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and therapy development.